Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041379
Filing Date
2023-08-10
Accepted
2023-08-10 16:26:10
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hsto-20230630.htm   iXBRL 10-Q 2728255
2 EX-10.1 hsto-ex10_1.htm EX-10.1 365301
3 EX-10.2 hsto-ex10_2.htm EX-10.2 111290
4 EX-31.1 hsto-ex31_1.htm EX-31.1 20768
5 EX-31.2 hsto-ex31_2.htm EX-31.2 20929
6 EX-32.1 hsto-ex32_1.htm EX-32.1 10084
7 EX-32.2 hsto-ex32_2.htm EX-32.2 10081
8 GRAPHIC img182844809_0.jpg GRAPHIC 33428
9 GRAPHIC img182844809_1.jpg GRAPHIC 13828
  Complete submission text file 0000950170-23-041379.txt   10536171

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hsto-20230630_lab.xml EX-101.LAB 573220
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hsto-20230630_pre.xml EX-101.PRE 413496
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hsto-20230630_cal.xml EX-101.CAL 50556
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hsto-20230630.xsd EX-101.SCH 70753
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hsto-20230630_def.xml EX-101.DEF 272142
56 EXTRACTED XBRL INSTANCE DOCUMENT hsto-20230630_htm.xml XML 1553076
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

EIN.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 231159941
SIC: 2834 Pharmaceutical Preparations